1Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029.
Engineered antibodies can display foreign peptides, stimulating T cell responses against the peptides and influenza virus. This approach offers a safe, long-lived alternative to current peptide-based vaccines.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: